Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients

Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients

Abstract Background The heterogeneous behavior of patients with melanoma makes prognostication challenging. To address this, a gene expression profile (GEP) test to predict metastatic risk was previously developed. This study evaluates the GEP’s prognostic accuracy in an independent cohort of cutane...

Full description

Bibliographic Details
Main Authors: Jonathan S. Zager, Brian R. Gastman, Sancy Leachman, Rene C. Gonzalez, Martin D. Fleming, Laura K. Ferris, Jonhan Ho, Alexander R. Miller, Robert W. Cook, Kyle R. Covington, Kristen Meldi-Plasseraud, Brooke Middlebrook, Lewis H. Kaminester, Anthony Greisinger, Sarah I. Estrada, David M. Pariser, Lee D. Cranmer, Jane L. Messina, John T. Vetto, Jeffrey D. Wayne, Keith A. Delman, David H. Lawson, Pedram Gerami
Format: Article
Language:English
Published: BMC 2018-02-01
Series:BMC Cancer
Subjects:
Gene expression profiling
DecisionDx-Melanoma
Cutaneous melanoma
Metastasis
Prognosis
Staging
Online Access:http://link.springer.com/article/10.1186/s12885-018-4016-3

Internet

http://link.springer.com/article/10.1186/s12885-018-4016-3

Similar Items